Akoya Biosciences Top Management

AKYADelisted Stock  USD 1.29  0.00  0.00%   
Akoya Biosciences employs about 205 people. The company is managed by 19 executives with a total tenure of roughly 479 years, averaging almost 25.0 years of service per executive, having 10.79 employees per reported executive. Analysis of Akoya Biosciences' management performance can provide insight into the company performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akoya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Akoya Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.1749) % which means that it has lost $0.1749 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.5427) %, meaning that it created substantial loss on money invested by shareholders. Akoya Biosciences' management efficiency ratios could be used to measure how well Akoya Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Akoya Biosciences Workforce Comparison

Akoya Biosciences is rated third in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 15,578. Akoya Biosciences claims roughly 205 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.59) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.8) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.8.

Akoya Biosciences Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Akoya Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Akoya Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Akoya Biosciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Akoya Biosciences Notable Stakeholders

An Akoya Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Akoya Biosciences often face trade-offs trying to please all of them. Akoya Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Akoya Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Brian McKelligonCEO PresidentProfile
Pascal BamfordResearch PresidentProfile
John EkPrincipal CFOProfile
John CPAPrincipal CFOProfile
Clifford HoytVP AffairsProfile
CFA CFASecretaryProfile
Marilee MBAChief OfficerProfile
Jennifer KamocsayGeneral CounselProfile
Nikolay SamusikCoFounderProfile
Anthony CatalanoSenior OperationsProfile
Niroshan RamachandranChief OfficerProfile
Priyam ShahSenior StrategyProfile
JD CFASecretaryProfile
Niro RamachandranChief OfficerProfile
Yury GoltsevCoFounderProfile
Joseph DriscollChief OfficerProfile
Garry NolanIndependent CoFounderProfile
Paul GrassSenior SalesProfile
Frederic PlaChief OfficerProfile

About Akoya Biosciences Management Performance

The success or failure of an entity such as Akoya Biosciences often depends on how effective the management is. Akoya Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Akoya management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Akoya management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. Akoya Biosciences operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 319 people.
Please note, the presentation of Akoya Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Akoya Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Akoya Biosciences' management manipulating its earnings.

Akoya Biosciences Workforce Analysis

Traditionally, organizations such as Akoya Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Akoya Biosciences within its industry.

Akoya Biosciences Manpower Efficiency

Return on Akoya Biosciences Manpower

Revenue Per Employee398.4K
Revenue Per Executive4.3M
Net Loss Per Employee270.1K
Net Loss Per Executive2.9M
Working Capital Per Employee230.7K
Working Capital Per Executive2.5M
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akoya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Akoya Stock

If you are still planning to invest in Akoya Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akoya Biosciences' history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance